Abstract:Induced pluripotent stem cells (iPSCs) have tremendous potential as a tool for disease modeling, drug testing, and other applications. Since the generation of iPSCs "captures" the genetic history of the individual cell that was reprogrammed, iPSC clones (even those derived from the same individual) would be expected to demonstrate genetic heterogeneity. To assess the degree of genetic heterogeneity, and to determine whether some cells are more genetically "fit" for reprogramming, we performed exome sequencing on 24 mouse iPSC clones derived from skin fibroblasts obtained from two different sites of the same 8-week-old C57BL/6J male mouse. While no differences in the coding regions were detected in the two parental fibroblast pools, each clone had a unique genetic signature with a wide range of heterogeneity observed among the individual clones: a total of 383 iPSC variants were validated for the 24 clones (mean 16.0/clone, range 0-45). Since these variants were all present in the vast majority of the cells in each clone (variant allele frequencies of 40-60% for heterozygous variants), they most likely preexisted in the individual cells that were reprogrammed, rather than being acquired during reprogramming or cell passaging. We then tested whether this genetic heterogeneity had functional consequences for hematopoietic development by generating hematopoietic progenitors in vitro and enumerating colony forming units (CFUs). While there was a range of hematopoietic potentials among the 24 clones, only one clone failed to differentiate into hematopoietic cells; however, it was able to form a teratoma, proving its pluripotent nature. Further, no specific association was found between the mutational spectrum and the hematopoietic potential of each iPSC clone. These data clearly highlight the genetic heterogeneity present within individual fibroblasts that is captured by iPSC generation, and suggest that most of the changes are random, and functionally benign.

Parallel genome-scale CRISPR-Cas9 screens uncouple human pluripotent stem cell identity versus fitness

Parallel genome-scale CRISPR screens distinguish pluripotency and self-renewal

Deconstructing Transcriptional Heterogeneity in Pluripotent Stem Cells

Association of Telomere Length with Authentic Pluripotency of ES/iPS Cells.

A Genome-Wide CRISPR Screen Identifies Factors Regulating Pluripotency Exit in Mouse Embryonic Stem Cells

A PERTURBATION CELL ATLAS OF HUMAN INDUCED PLURIPOTENT STEM CELLS

Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations

A multi-omics integrative analysis based on CRISPR screens re-defines the pluripotency regulatory network in ESCs

Genome-wide gain-of-function screen identifies novel regulators of pluripotency.

Genetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouse

A genome-scale single cell CRISPRi map of trans gene regulation across human pluripotent stem cell lines

Complex regulatory networks influence pluripotent cell state transitions in human iPSCs

Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency

Mapping germ-layer specification preventing genes in hPSCs via genome-scale CRISPR screening

A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity

A CRISPR/Cas9-based Kinome Screen Identifies ErbB Signaling As a New Regulator of Human Naïve Pluripotency and Totipotency

A CRISPR/Cas9 screen in embryonic stem cells reveals that Mdm2 regulates totipotency exit

Characterization of human pluripotent stem cell differentiation by single-cell dual-omics analyses

Identifying Candidate Reprogramming Genes in Mouse Induced Pluripotent Stem Cells

Genome-Wide CRISPR Screen Identifies Puf60 As a Novel Stemness Gene of Mouse Embryonic Stem Cells

Single Cell Transcriptional Profiling Reveals Heterogeneity of Human Induced Pluripotent Stem Cells